Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure



Rating:

Share or cite this content

Citations should be made in the following way:
R. Vollenberg (Münster, Germany), M. Strauss (Muenster, Germany), K. Schuette-Nuetgen (Muenster, Germany), H. Schmidt (Muenster, Germany), A. Schulze (Muenster, Germany), P. Tepasse (Muenster, Germany). COVID-19 patient with acute respiratory distress syndrome (ARDS) benefit most from an early prone position. 908

Member's Comments

No comment yet.

Related content which might interest you: Long term effects of prone position in acute respiratory distress syndrome (ARDS) Source: Annual Congress 2008 - Acute lung injury and weaning Year: 2008 Prone position in acute respiratory distress syndrome Source: Eur Respir J 2002; 20: 1017-1028 Year: 2002 An animal model of the acute respiratory distress syndrome (ARDS) Source: Eur Respir J 2002; 20: Suppl. 38, 486s Year: 2002 Corticosteroids and acute respiratory distress syndrome (ARDS) Source: Annual Congress 2007 - Corticosteroids and respiratory failure Year: 2007 Proteinomics and ARDS Source: Annual Congress 2007 - Acute respiratory distress syndrome: from basic science to bedside Year: 2007 Prone position in acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=143 Year: 2002 Impaired ventilation is not independently associated with 28-day mortality in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) Source: Virtual Congress 2021 – COVID-19 acute respiratory distress syndrome Year: 2021 Current invasive ventilatory strategies in acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=161 Year: 2002 Prone position reduces lung stress and strain in severe acute respiratory distress syndrome Source: Eur Respir J 2005; 25: 534-544 Year: 2005 Acute respiratory distress in infants and young children [respiratory distress syndrome (RDS), acute RDS (ARDS), and bronchiolotis] Source: International Congress 2014 – Noninvasive respiratory support for infants and young children Year: 2014 Acute increase in KL-6/MUC1 mucin as a potential trigger of disseminated intravascular coagulation in acute respiratory distress syndrome Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management Year: 2006 NIV: indication in case of acute hypoxaemic respiratory failure (pulmonary oedema and immunosuppressed patients excluded) Source: Eur Respir Mon; 2008: 41: 60–71 Year: 2008 Acute respiratory distress syndrome Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=49 Year: 2006 The impact of two partial ventilatory support modalities on lung histology and inflammatory mediators in a model of acute respiratory distress syndrome Source: Annual Congress 2007 - Acute lung injury and inflammation Year: 2007 KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome Source: Eur Respir J 2004; 23: 142-145 Year: 2004 Surfactant therapy in acute lung injury/acute respiratory distress syndrome Source: Eur Respir Mon 2012; 55: 54-64 Year: 2012 Epidemiology and prognosis of acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=1 Year: 2002 Pulmonary function in patients recovering from severe acute respiratory syndrome (SARS) Source: Eur Respir J 2004; 24: Suppl. 48, 239s Year: 2004 Exogenous pulmonary surfactant combined with recruitment maneuver in prevention of alveolar derecruitment in rabbits with acute respiratory distress syndrome Source: Annual Congress 2007 - Lung recruitment Year: 2007 Prognostic score of prone positioning to predict outcome in paients with moderate to severe acute respiratory distress syndrome Source: Virtual Congress 2020 – Novel findings regarding acute respiratory distress syndrome, extra corporeal membrane oxygenation and weaning from mechanical ventilation Year: 2020